The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Repurposing tin mesoporphyrin as a novel immune checkpoint therapy in the treatment of cancer: A preclinical evaluation.
 
James N. Arnold
No Relationships to Disclose
 
Tamara Muliaditan
No Relationships to Disclose
 
James W. Opzoomer
No Relationships to Disclose
 
Jonathan Caron
No Relationships to Disclose
 
Mary Okesola
No Relationships to Disclose
 
Paris Kosti
No Relationships to Disclose
 
Sharanpreet Lall
No Relationships to Disclose
 
Mieke Van Hemelrijck
No Relationships to Disclose
 
Francesco Dazzi
No Relationships to Disclose
 
Andrew Tutt
No Relationships to Disclose
 
Anita Grigoriadis
No Relationships to Disclose
 
Cheryl Gillett
No Relationships to Disclose
 
Stephen F. Madden
No Relationships to Disclose
 
Joy M Burchell
No Relationships to Disclose
 
Shahram Kordasti
No Relationships to Disclose
 
Sandra S. Diebold
No Relationships to Disclose
 
James F. Spicer
Stock and Other Ownership Interests - IGEA
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst)